Todd Franklin Watanabe - 27 Feb 2026 Form 4 Insider Report for Arcutis Biotherapeutics, Inc. (ARQT)

Reporting relationship: Reporting Person's title: President and Chief Executive Officer, Director
Issuer ticker: ARQT
Reported as of: 27 Feb 2026
Net transaction value: -$940,528
SEC form: 4
Accepted by SEC: 03 Mar 2026, 20:42:43 UTC
Prior SEC filing: 04 Feb 2026
Next SEC filing: 06 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Latha Vairavan, as Attorney-in-Fact for Todd Franklin Watanabe

Key filing fact

Todd Franklin Watanabe filed Form 4 for Arcutis Biotherapeutics, Inc. (ARQT) on 03 Mar 2026.

Key facts

This page summarizes Todd Franklin Watanabe's Form 4 filing for Arcutis Biotherapeutics, Inc. (ARQT).
4 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 03 Mar 2026, 20:42.

Change

Previous filing in this sequence was filed on 04 Feb 2026.
Current net transaction value: -$940,528.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001801061 Primary reporting owner

Watanabe Todd

Relationship: Reporting Person's title: President and Chief Executive Officer, Director
Address: C/O ARCUTIS BIOTHERAPEUTICS, INC., 3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE
Signature: /s/ Latha Vairavan, as Attorney-in-Fact for Todd Franklin Watanabe
Signature date: 03 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ARQT transaction

Common Stock

Award

Transaction value: $0
Shares: +102,000
Change %: +14%
Price: $0.000000
Shares after: 823,306
Date: 27 Feb 2026
Ownership: Direct
Footnotes: F1

ARQT transaction

Common Stock

Sale

Transaction value: $912,852
Shares: -36,281
Change %: -4.4%
Price: $25.16
Shares after: 787,025
Date: 02 Mar 2026
Ownership: Direct
Footnotes: F2, F3

ARQT transaction

Common Stock

Sale

Transaction value: $27,676
Shares: -1,068
Change %: -0.14%
Price: $25.91
Shares after: 785,957
Date: 02 Mar 2026
Ownership: Direct
Footnotes: F2, F4

ARQT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 25,410
Date: 27 Feb 2026
Ownership: By Trust
Footnotes: F5

ARQT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 25,410
Date: 27 Feb 2026
Ownership: By Trust
Footnotes: F6

ARQT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 57,358
Date: 27 Feb 2026
Ownership: By LLC
Footnotes: F7

ARQT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 124,956
Date: 27 Feb 2026
Ownership: By Trust
Footnotes: F8

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ARQT transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +266,000
Change %
Price: $0.000000
Shares after: 266,000
Date: 27 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 266,000
Exercise price: $26.97
Footnotes: F9

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 9 footnotes

Footnote F1

Constitute Restricted Stock Units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon vesting, in which 25% of the RSUs vest annually on March 1, (the "Vesting Commencement Date"), of each year beginning March 1, 2027, subject to the Reporting Person's continued service to the Issuer.

Footnote F2

The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs.

Footnote F3

The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $24.6850 to $25.67, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Footnote F4

The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $25.70 to $26.10, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Footnote F5

The securities are held of record by The John Franklin Watanabe Trust, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.

Footnote F6

The securities are held of record by The Anderson Prest Watanabe Irrevocable Trust, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.

Footnote F7

The securities are held of record by Watanabe Ventures, LLC, of which the Reporting Person is the Chief Operating Officer. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.

Footnote F8

The securities are held of record by The Watanabe 2016 Irrevocable Trust, of which the Reporting Person's children are beneficiaries. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.

Footnote F9

1/48th of the shares subject to the option vest on each monthly anniversary measured from March 1, 2026 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer.

SEC remarks

Reporting Person's title: President and Chief Executive Officer